Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
92.50    -0.10 (-0.11%)
Bid:
92.90
Ask:
94.00
Spread: 1.10 (1.184%)
Market Cap: £642.50m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Board changes

19 Jan 2026 07:00

RNS Number : 3175P
GlobalData PLC
19 January 2026
 

19 January 2026

 

 

GlobalData Plc (GlobalData; the Company)Board changes

 

GlobalData Plc, a leading data, insights, and technology company, is pleased to announce the appointment of Rachel Higham as an independent non-executive director with effect from 20 January 2026.

Rachel brings to the board more than 30 years of experience in the information technology sector, having held senior roles at Marks & Spencer, WPP, BT and Vodafone.

In accordance with Schedule 2(g) of the AIM Rules for Companies, Rachel Higham is 51 years old. In the last 5 years she has been, and still is, a director at RHigham Consulting Limited and director and trustee at Macmillan Cancer Support. There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

This appointment is part of wider changes being announced with respect to the board's independent non-executive directorships. Both Annette Barnes and Andrew Day will not offer themselves for re-election as a director at the 2026 Annual General Meeting given they would, at that time, have served on the board for more than nine years from the date of their first appointment. Annette and Andrew will resign from office prior to the Company announcing its 2025 full year results on 2 March 2026.

Rachel is being appointed to succeed Andrew Day and a further appointment to succeed Annette Barnes is expected to be announced shortly. 

 

Mike Danson, Chief Executive Officer of GlobalData, commented:

"On behalf of the board, I would like to thank Annette and Andrew for their exceptional support and guidance over the last nine years during which time GlobalData has evolved into a globally recognised market leader. We wish them all the best for the future."

"I am also delighted to welcome Rachel to the GlobalData team. Rachel will bring a wealth of knowledge and expertise to our board both from her experiences within the technology sector, but also from her focus and passion for data and innovation.''

 

-ENDS-

 

 

ENQUIRIES

GlobalData Plc

0207 936 6400

Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0203 100 2000

Rupert Dearden

James Sinclair-Ford

 

Investec Bank plc (Joint Broker)

Henry Reast

0207 597 5970

Virginia Bull

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQWGUPQPUQ
Date   Source Headline
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change
1st Jun 20214:26 pmRNSPDMR Dealing
30th Apr 20217:00 amRNSBoard Change
20th Apr 202110:56 amRNSResults of AGM
26th Mar 20217:00 amRNSNotice of AGM and the proposed appointment of NED
26th Mar 20217:00 amRNSInterim Accounts
15th Mar 20217:00 amRNSAnnual Report
1st Mar 20217:01 amRNSBoard Changes
1st Mar 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
12th Feb 20214:12 pmRNSHolding(s) in Company
18th Jan 20219:17 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSBoard Changes
21st Dec 20209:49 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSAppointment of Nomad and Broker
25th Nov 20207:00 amRNSTrading Update
9th Oct 20203:47 pmRNSTransfer of Shares out of Treasury
1st Sep 202012:16 pmRNSHolding(s) in Company
21st Aug 20208:55 amRNSAppointment of Joint Corporate Broker
27th Jul 20207:00 amRNSUnaudited Interim Report
21st May 20204:10 pmRNSEmployee Share Options and PDMR Dealing
19th May 20201:06 pmRNSIncreased Banking Facilities
21st Apr 202011:05 amRNSResults of AGM
21st Apr 20207:00 amRNSCOVID-19 Update, Dividend Deferral and AGM
27th Mar 202011:55 amRNSNotice of AGM
3rd Mar 20207:45 amRNSAnnual Report and Accounts
24th Feb 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
16th Jan 20207:00 amRNSUpdate on Directorate Change
30th Oct 201910:59 amRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSUnaudited Interim Report
19th Jul 20197:00 amRNSNotice of Results
23rd May 20197:00 amRNSNotice of Capital Markets Day
26th Apr 201912:57 pmRNSDirector/PDMR Dealings
23rd Apr 20194:20 pmRNSResults of AGM
28th Mar 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
11th Mar 201911:41 amRNSPDMR Dealing
25th Feb 20197:00 amRNSFinal Results For The Year Ended 31 December 2018
17th Oct 20182:47 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUnaudited Interim Report
4th May 20181:20 pmRNSDirector/PDMR Shareholding
30th Apr 20182:01 pmRNSHolding(s) in Company
27th Apr 20188:14 amRNSDirector/PDMR Shareholding
24th Apr 20181:14 pmRNSResult of General Meeting and AGM
29th Mar 20187:00 amRNSProposed Acquisition
26th Feb 20187:01 amRNSFinal Results For The Year Ended 31 December 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.